{
  "docId": "019dd923-622c-750b-8b9a-2a2468219173",
  "docSlug": "ce565b841c40",
  "documentTitle": "Nevro Corp. (NVRO)",
  "authorId": "58_Scorpion_Capital",
  "authorName": "Kir Kahlon",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2021-01-07 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 142,
  "pageCount": 239,
  "prevPage": 141,
  "nextPage": 143,
  "slideType": "villain_critique",
  "function": "illustrate_case",
  "density": "overcrowded",
  "nDataPoints": 3,
  "notes": "Uses highlighted text blocks to emphasize key negative quotes from industry experts regarding Nevro's product launch.",
  "elementsJson": [
    "headline_text",
    "bullet_list",
    "quote_block",
    "footnote"
  ],
  "metadataConfidence": 0.9,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9a-2a2468219173/142",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-142",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "Omnia isn’t impacting the market by letting them capture market share. Doctors use everyone. They’re not loyal. The only loyal ones are ones being paid a lot of money to put in devices.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-3f3d-76db-b344-4ccc4a8b45a8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.88,
        "x": 0.06,
        "y": 0.6
      },
      "kind": "list",
      "text": "A longtime C-level executive in the SCS space stated that a me-too product like Omnia wouldn't shift any share to Nevro",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "334579c2-7572-4c74-bdda-08fe4ffa3b89",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.88,
        "x": 0.06,
        "y": 0.25
      },
      "kind": "list",
      "text": "A territory manager with 20 years of SCS experience, overseeing one of the largest multi-state regions for one of Nevro's 3 key competitors, described a few doctors dabbling with Omnia but no material market share impact.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "831bb42e-29fd-4567-97e5-51e8c490e305",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.21,
        "w": 0.83,
        "x": 0.11,
        "y": 0.36
      },
      "kind": "quote",
      "text": "\"Omni rolled out in Q3 2019. We're seeing it all over social media... Omnia isn't impacting the market by letting them capture market share. Doctors use everyone. They're not loyal. The only loyal ones are ones being paid a lot of money to put in devices.\"",
      "attrs": {
        "highlighted": true
      },
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "95bbe90e-4f6d-483c-8f43-1990c9218537",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.83,
        "x": 0.11,
        "y": 0.68
      },
      "kind": "quote",
      "text": "\"Are they shifting share from Boston Scientific with Omnia? I doubt it because Boston Scientific, their IPG, has those capabilities, and I think their programming is better.\"",
      "attrs": {
        "highlighted": true
      },
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e0743819-8339-454b-b93e-12ee97a721df",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "“Omni rolled out in Q3 2019. We’re seeing it all over social media. Doctors are saying Omnia’s a good battery, that it gives them options but that the results are no better than anyone’s else. They got some more play with it. One of our doctors will do a couple of cases with it and see how it goes. You have your Nevro loyalists like [name redacted] and [name redacted] who are being paid. They’re on their studies. Every day doctors though have gotten smarter and use everyone’s device. Omnia isn’t impacting the market by letting them capture market share. Doctors use everyone. They’re not loyal. The only loyal ones are ones being paid a lot of money to put in devices. Everyone gets their piece of the pie.” — Territory manager at one of Nevro’s 3 key competitors; “Are they shifting share from Boston Scientific with Omnia? I doubt it because Boston Scientific, their IPG, has those capabilities, and I think their programming is better.” — Longtime executive in the SCS space",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd953-3f3d-76db-b344-50c5402a67d8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.2,
        "x": 0.06,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "Source: Consultation calls with experts",
      "attrs": null,
      "subkind": "source-note",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "478c1fe0-a20e-482e-8f1d-375cb77afa15",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.13,
        "w": 0.88,
        "x": 0.06,
        "y": 0.09
      },
      "kind": "title",
      "text": "10. The new Omnia stimulator, the centerpiece of Nevro's turnaround hopes, is a Hail Mary and colossal flop\nExecutives, regional managers, and sales reps at Nevro's competitors... offered ground-level color on Omnia, corroborating remarks by doctors and ex-employees that it's a failed launch with little to no market impact.",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "28c5c1ac-3a39-40a7-a370-02b8c750ded5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.45,
        "x": 0.06,
        "y": 0.04
      },
      "kind": "title",
      "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "eae5e698-f04f-4479-9bf1-85940addd4d2",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Audience Definition",
      "slug": "audience-definition",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "b331783e-b247-40e6-8307-813d90602ebd",
      "evidence": "The use of quotes from experts and KOLs to support the allegations about Nevro's practices and target audience.",
      "confidence": 0.5
    }
  ],
  "frameworks": [
    {
      "name": "authority-citation",
      "slug": null,
      "matchId": "70abdf40-3d9d-4365-936f-adba9ecb7f43",
      "evidence": "Citing a territory manager with 20 years of SCS experience and a longtime C-level executive to validate the short thesis.",
      "confidence": 0.85
    }
  ],
  "arcBeats": [
    {
      "to": 150,
      "from": 51,
      "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
      "arcName": "Overcoming the Monster",
      "arcSlug": "overcoming-monster",
      "beatName": "The Victory",
      "beatSlug": "overcoming-monster-the-victory",
      "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}